fluoxetine has been researched along with metyrapone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gerken, A; Holsboer, F; Steiger, A; von Bardeleben, U | 1 |
| Altemus, M; DeBattista, C; Kocsis, JH; Lopez, JF; Schatzberg, AF; Young, EA; Zubieta, JK | 1 |
| Bondarenko, E; Carnevali, L; Day, TA; Head, GA; Lukoshkova, EV; Nalivaiko, E; Sgoifo, A; Walker, FR | 1 |
1 review(s) available for fluoxetine and metyrapone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for fluoxetine and metyrapone
| Article | Year |
|---|---|
Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls.
Topics: Adrenocorticotropic Hormone; Adult; Cortodoxone; Electroencephalography; Fluoxetine; Hormones; Humans; Hydrocortisone; Male; Metyrapone; Penile Erection; Sleep; Sleep, REM | 1989 |
HPA axis activation in major depression and response to fluoxetine: a pilot study.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Second-Generation; Circadian Rhythm; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hypothalamo-Hypophyseal System; Metyrapone; Middle Aged; Pilot Projects; Pituitary-Adrenal System; Stimulation, Chemical; Treatment Outcome | 2004 |
5 other study(ies) available for fluoxetine and metyrapone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Metyrapone and fluoxetine suppress enduring behavioral but not cardiac effects of subchronic stress in rats.
Topics: Animals; Behavior, Animal; Circadian Rhythm; Corticosterone; Electric Stimulation; Fluoxetine; Heart Rate; Male; Metyrapone; Models, Animal; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Physiological; Vagus Nerve | 2011 |